Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

OMIS

Financiado

Cerrado

Feasibility study on Opto Magnetic Imaging Spectroscopy for cancer screening

Cancer is among the leading causes of death in the modern world with over 8 million cancer related deaths globally and over 1 million in the EU. The estimated economic costs of this EU social problem in 2009 was over €120 billion... ver más

31/08/2016

COMMUNITY CPR TRUS...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

COMMUNITY CPR TRUST CIC No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2016-08-31

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

COMMUNITY CPR TRUST CIC

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RTC-2015-4167-1 DESARROLLO DE UNA PLATAFORMA COMPLETA PARA EL ANÁLISIS DE CÉ... 849K€ Cerrado

DPI2015-68442-R ANALISIS DE IMAGENES INTELIGENTE PARA LOS RETOS EN EL CRIBAD... 138K€ Cerrado

RTC-2015-3287-1 Desarrollo de un algoritmo diagnóstico multimodal incluyendo... 193K€ Cerrado

MIRACLE Magnetic Isolation and moleculaR Analysis of single CircuLat... 9M€ Cerrado

ColoFast Developing a Non Invasive Kit for Early Colorectal Cancer De... 3M€ Cerrado

CADe4BMRI Improved detection and characterisation of breast cancer usi... 88K€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2016-02-25
Fecha Fin: 2016-08-31

Líder del proyecto

COMMUNITY CPR TRUST CIC No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is among the leading causes of death in the modern world with over 8 million cancer related deaths globally and over 1 million in the EU. The estimated economic costs of this EU social problem in 2009 was over €120 billion with the healthcare costs at 40% of this amount. Early identification of cancers continues as a key priority to reducing loss of life and subsequent treatment costs. Screening for cervical cancer is very effective at controlling the disease, but the costs for the 32 million women involved in EU screening programmes costs approximately €960 million per year. Tumour Trace Limited have developed OMIS, an innovative cancer screening methodology and device which offers a reduction of 75% costs for laboratories and accuracy of over 95%. This technology uses Opto-Magnetic Imaging Spectroscopy (OMIS) to provide an objective cancer diagnosis and offers a step change in accuracy, costs and speed of screening. Current methods are expensive, time consuming and subject to false results as the screening technologies rely on pathology judgements rather than objective molecular biophysical properties that are measured by OMIS. Tumour Trace have validated this technology with several pre-clinical studies for cervical cancer, prostate cancer and colon cancer. Tumour Trace have plans to commercialise this technology in cervical cancer screening programmes initially for the UK, Serbia and India; however further market research included in this Phase 1 application is required to support uptake across the wider EU market and to explore the potential impact in other cancer areas. This ground breaking technology will lead to improved clinical decision making and better health outcomes through earlier cancer detections and a reduction of false results; this in turn will contribute to more efficient sustainable healthcare provision.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores